Search

Your search keyword '"Plaseska-Karanfilska D."' showing total 356 results

Search Constraints

Start Over You searched for: Author "Plaseska-Karanfilska D." Remove constraint Author: "Plaseska-Karanfilska D."
356 results on '"Plaseska-Karanfilska D."'

Search Results

1. ANXA5 and VEGFA Gene Variants in Women with Early Pregnancy Losses from North Macedonia

2. Study of Three Single Nucleotide Polymorphisms in the Slc6a14 Gene in Association with Male Infertility

3. Chromosomal Abnormalities in Early Pregnancy Losses: A Study of 900 Samples

4. Two Brothers from Macedonia with Gitelman Syndrome

5. Androgen Insensitivity Syndrome DUE to Non-Coding Variation in the Androgen Receptor Gene: Review of the Literature and Case Report of a Patient with Mosaic c.-547C>T Variant

6. de novo TINF2 C.845G>A: Pathogenic Variant in Patient with Dyskeratosis Congenita

7. ANXA5and VEGFAGene Variants in Women with Early Pregnancy Losses from North Macedonia

9. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

10. Rare germline copy number variants (CNVs) and breast cancer risk

11. Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study

12. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

13. Rare germline copy number variants (CNVs) and breast cancer risk

15. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

18. CYP3A7*1C allele:linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

19. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

20. Breast cancer risk factors and survival by tumor subtype: Pooled analyses from the breast cancer association consortium.

21. Mendelian randomisation study of smoking exposure in relation to breast cancer risk.

22. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.

23. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.

24. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.

25. Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium

26. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

27. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

28. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

29. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

30. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

31. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

32. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk

33. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

34. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

35. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

36. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

37. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

38. Two truncating variants in FANCC and breast cancer risk.

39. The spectrum of fancm protein truncating variants in European breast cancer cases.

40. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

41. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.

42. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

43. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

44. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

45. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

46. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

47. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

48. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

49. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

50. The Spectrum of FANCM Protein Truncating Variants in European Breast Cancer Cases

Catalog

Books, media, physical & digital resources